26 related articles for article (PubMed ID: 38537960)
1. Volume-based
Liu DN; Li CP; Li HW; Wang HY; Tian XY; Hao CY
Abdom Radiol (NY); 2024 Mar; 49(3):958-963. PubMed ID: 38245900
[TBL] [Abstract][Full Text] [Related]
2. PET/MRI in Endometrial Cancer: Imaging Biomarkers are Associated with Disease Progression and Overall Survival.
Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Zheng QY; Cheng MF; Chen JL; Shih TT
Acad Radiol; 2024 Mar; 31(3):939-950. PubMed ID: 37714718
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the expression of PD-L1 and
Li J; Chen R; Chen Y; Xia Q; Zhou X; Xia Q; Wang C; Wan L; Bao H; Huang G; Liu J
Br J Cancer; 2023 Aug; 129(3):541-550. PubMed ID: 37311977
[TBL] [Abstract][Full Text] [Related]
4. Achieving long-term survival in extensive-stage SCLC: a case report and mini literature review.
Mao Y; Huang M; Liu J
Lung Cancer Manag; 2024; 13(1):LMT64. PubMed ID: 38818367
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer].
Ding CY; Guo Z; Li YY; Li TR
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):828-834. PubMed ID: 29151289
[No Abstract] [Full Text] [Related]
6. Prognostic Potential of Metabolic Activity on 18 F-FDG Accumulation in Advanced NSCLC Receiving Combining Chemotherapy Plus PD-1 Blockade.
Hashimoto K; Kaira K; Imai H; Mouri A; Shiono A; Miura Y; Yamaguchi O; Kobayashi K; Kagamu H; Kuji I
J Immunother; 2022 Oct; 45(8):349-357. PubMed ID: 35980360
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).
Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M
Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543
[TBL] [Abstract][Full Text] [Related]
8. The correlation between PD-L1 expression and metabolic parameters of
Xu X; Li J; Yang Y; Sang S; Deng S
Clin Imaging; 2022 Sep; 89():120-127. PubMed ID: 35797878
[TBL] [Abstract][Full Text] [Related]
9. New insight on the correlation of metabolic status on
Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Tumor Volume as Significant Predictor for Chemotherapy Containing PD-L1 Blocker in Extensive Stage Small Cell Lung Cancer.
Hashimoto K; Kaira K; Imai H; Miura YU; Shiono A; Mouri A; Yamaguchi OU; Kobayashi K; Kagamu H; Kuji I
Anticancer Res; 2024 Apr; 44(4):1541-1551. PubMed ID: 38537960
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
Liu J; Dong M; Sun X; Li W; Xing L; Yu J
PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of MTV and TLG of
Wen W; Piao Y; Xu D; Li X
Contrast Media Mol Imaging; 2021; 2021():7528971. PubMed ID: 34887713
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]